Estimating the direct and indirect costs for community-dwelling patients with schizophrenia

Journal of Pharmaceutical Health Services Research

Volumn 4, Issue 4, 2013, Pages 187-194

  Desai, Pooja R ^a   Lawson, Kenneth A ^a   Barner, Jamie C ^a   Rascati, Karen L ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Community dwelling residents; Medical Expenditure Panel Survey; Schizophrenia related costs; USA

Indexed keywords

PRESCRIPTION DRUG;

ARTICLE; CAREGIVER; COMMUNITY; DEATH; EMERGENCY WARD; EMPLOYMENT; HEALTH CARE; HEALTH CARE COST; HEALTH SURVEY; HOSPITALIZATION; HUMAN; ICD-9; MAJOR CLINICAL STUDY; OUTPATIENT; PRIORITY JOURNAL; PRODUCTIVITY; PROFESSIONAL PRACTICE; SCHIZOPHRENIA; SENSITIVITY ANALYSIS; UNEMPLOYMENT; UNITED STATES;

EID: 84887411806     PISSN: 17598885     EISSN: 17598893     Source Type: Journal    
DOI: 10.1111/jphs.12027     Document Type: Article

References (39)

1. MedLine Plus. Schizophrenia [online]. Bethesda, MD: National Institutes of Health, 2013. http://www.nlm.nih.gov/medlineplus/ency/article/000928.htm (accessed 15 October 2010).
2. Kessler RC etal. The prevalence and correlates of non-affective psychosis in the National Comorbidity Survey Replication (NCS-R). Biol Psychiatry 2005; 15: 668-676.
3. Robins LN, Regier DA. Psychiatric Disorders in America: The Epidemiologic Catchment Area Study. New York: The Free Press, 1991.
4. Gunderson GJ, Mosher LR. The cost of schizophrenia. Am J Psychiatry 1975; 132: 901-906.
5. Rice DP, Miller LS. The economic burden of schizophrenia: conceptual and methodological issues, and cost estimates. In: Rupp A etal., eds. Handbook of Mental Health Economics and Health Policy, Vol. 1. New York: John Wiley, 1996: 321-334.
6. Rice DP. The economic impact of schizophrenia. J Clin Psychiatry 1999; 60: 4-6.
7. Wyatt RJ etal. An economic evaluation of schizophrenia. Soc Psychiatry Psychiatr Epidemiol 1995; 30: 196-205.
8. Wu EQ etal. The economic burden of schizophrenia in the United States in 2002. J Clin Psychiatry 2005; 66: 1122-1129.
9. McDonald M etal. Health care spending for community-dwelling adults with schizophrenia. Am J Manag Care 2005; 11: S242-S247.
10. Terkelsen KG, Menikoff A. Measuring the cost of schizophrenia. Implications for a post institutional era in the US. Pharmacoeconomics 1995; 8: 199-222.
11. Hu TW etal. Estimating costs of schizophrenia and its treatment. In: Rupp A etal., eds. Handbook of Mental Health Economics and Health Policy, Vol. 1. New York: John Wiley, 1996: 359-371.
12. Centers for Disease Control and Prevention. Cost Analysis: Cost of Illness [online]. Atlanta, GA: Centers for Disease Control, undated. http://www.cdc.gov/owcd/eet/Cost/fixed/3.html (accessed 23 April 2013).
13. Cohen CI etal. Schizophrenia and older adults, an overview: directions for research policy. Am J Geriatr Psychiatry 2000; 8: 19-28.
14. Medical Expenditure Panel Survey. Survey Background [online]. Rockville, MD: Agency for Healthcare Research and Quality, 2009. http://www.meps.ahrq.gov/mepsweb/about_meps/survey_back.jsp (accessed 15 October 2010).
15. Medical Expenditure Panel Survey. MEPS HC-036: 1996-2007 Pooled Estimation File [online]. Rockville, MD: Agency for Healthcare Research and Quality, 2010. http://meps.ahrq.gov/mepsweb/data_stats/download_data/pufs/h36/h36u07doc.shtml (accessed 29 October 2012).
16. United States Bureau of Labor Statistics. Consumer Price Index [online]. Washington, DC: US Bureau of Labor Statistics, 2013. http://www.bls.gov/cpi/ (accessed 31 October 2012).
17. United S Employment Status of the Civilian Non-Institutional Population, 1940 to Date [2008] [online]. Washington, DC: US Bureau of Labor Statistics, undated. ftp://ftp.bls.gov/pub/special.requests/lf/aa2008/pdf/cpsaat1.pdf (accessed 25 November 2010).
18. Drake RE etal. Regional variation in competitive employment for people with severe mental illnesses. Adm Policy Ment Health 1999; 25: 493-504.
19. Mueser KT etal. A prospective analysis of work in schizophrenia. Schizophr Bull 2000; 27: 281-296.
20. Slade E, Salkever D. Symptoms effects on employment in a structural model of mental illnesses and treatment: analysis of patients with schizophrenia. J Ment Health Policy Econ 2001; 4: 25-34.
21. Bushe C etal. Mortality in schizophrenia - a measurable clinical endpoint. J Psychopharmacol 2010; 24: 17-25.
22. Saha S etal. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry 2007; 64: 1123-1131.
23. Pompili M etal. Suicide risk in schizophrenia: learning from the past to change the future. Ann Gen Psychiatry 2007; 6: 10.
24. Hor K, Taylor M. Suicide and schizophrenia: a systemic review of rates and risk factors. J Psychopharmacol 2010; 24: 81-90.
25. Heila H etal. Suicide and schizophrenia: a nationwide psychological autopsy study on age- and sex-specific clinical characteristics of 92 suicide victims with schizophrenia. Am J Psychiatry 1997; 154: 1235-1242.
26. Gold MR etal. Cost Effectiveness in Health and Medicine. New York: Oxford University Press, 1996.
27. McGuire TG. Measuring the economic costs of schizophrenia. Schizophr Bull 1991; 17: 375-388.
28. Rascati KL. Essentials of Pharmacoeconomics. Philadelphia, PA: Lippincott Williams & Wilkins, 2009.
29. McEvoy JP. The costs of schizophrenia. J Clin Psychiatry 2007; 68 (Suppl. 14): 4-7.
30. Khaykin E etal. Health insurance coverage among persons with schizophrenia in the United States. Psychiatr Serv 2010; 61: 830-834.
31. Greenberg PE etal. The economic burden of depression in the United States: how did it change between 1990 and 2000? J Clin Psychiatry 2003; 64: 1465-1476.
32. Bhugra D. The global prevalence of schizophrenia. PLoS Med 2005; 2: e151.
33. Zuvekas SH, Olin GL. Validating household reports of health care use in the medical expenditure panel survey. Health Serv Res 2009; 44(5 Pt 1): 1679-1700.
34. Malone DC etal. A cost-of-illness study of allergic rhinitis in the United States. J Allergy Clin Immunol 1997; 99: 22-27.
35. Buckley PF etal. Psychiatric comorbidities and schizophrenia. Schizophr Bull 2009; 35: 383-402.
36. Genduso LA, Haley JC. Cost of illness studies for schizophrenia: components, benefits, results, and implications. Am J Manag Care 1997; 3: 873-877.
37. Behan C etal. The economic cost of schizophrenia in Ireland: a cost of illness study. Ir J Psychol Med 2008; 25: 80-87.
38. Tarricone R etal. Direct and indirect costs of schizophrenia in the community psychiatric services in Italy The GISIES study. Health Policy 2000; 51: 1-18.
39. Jacobson G etal. Medicare Spending and Use of Medical Services for Beneficiaries in Nursing Homes and Other Long-Term Care Facilities: A Potential for Achieving Medicare Savings and Improving the Quality of Care [online]. Menlo Park, CA: The Henry J. Kaiser Family Foundation, 2010. http://kaiserfamilyfoundation.files.wordpress.com/2013/01/8109.pdf (accessed 12 April 2010).